Skip to main content
. 2015 Sep 23;2015(32):6965–6982. doi: 10.1002/ejoc.201500852

Scheme 19.

Scheme 19

ω-TA-catalyzed key steps of chemo-enzymatic routes for the manufacture of a) the antiallergic CRTH2 antagonist MK-7246 (42), b) the anticarcinogenic smoothened receptor (SMO) inhibitor 45, and c) the silodosin intermediate 49.